Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
12.11
1.48 (13.92%)
At close: Jun 02, 2025, 3:59 PM
12.21
0.83%
Pre-market: Jun 03, 2025, 04:00 AM EDT
13.92% (1D)
| Bid | 11.71 |
| Market Cap | 923.21M |
| Revenue (ttm) | 56.42M |
| Net Income (ttm) | -208.4M |
| EPS (ttm) | -2.79 |
| PE Ratio (ttm) | -4.34 |
| Forward PE | -3.32 |
| Analyst | Buy |
| Ask | 12.71 |
| Volume | 2,123,736 |
| Avg. Volume (20D) | 977,828 |
| Open | 11.12 |
| Previous Close | 10.63 |
| Day's Range | 11.11 - 12.52 |
| 52-Week Range | 8.18 - 29.56 |
| Beta | 2.24 |
About NRIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
+14.21%
Nurix Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+6.78%
Nurix Therapeutics shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a price target of $35.
